4/A: NeuroMetrix Director Joshua Horowitz Amends Form 4 to Correct Inadvertent Stock Sale

Joshua Horowitz, a director at NeuroMetrix, Inc., filed an amendment to his Form 4 to report an inadvertent sale of 1,000 shares of common stock at $4.58 per share on April 22, 2024.

Summary

• This is an amendment to a Form 4 filing by Joshua Horowitz, a director at NeuroMetrix, Inc.
• The amendment corrects an error in the original Form 4 filed on April 22, 2024.
• The original filing did not report an inadvertent sale of 1,000 shares of NeuroMetrix common stock at $4.58 per share on April 22, 2024.
• Horowitz also received 16,438 restricted stock units (RSUs) on April 18, 2024, as part of his compensation for serving on the Board of Directors.
• These RSUs vest in four equal quarterly installments starting June 30, 2024, with full vesting occurring on the earlier of the 2025 annual meeting or a change in control.
• After the reported transactions, Horowitz directly owns 23,438 shares and indirectly owns 60,500 shares through Palm Global Small Cap Master Fund LP.

Sentiment

Score: 7

Explanation: The document is a routine regulatory filing correcting a minor error. It doesn't indicate any significant positive or negative developments for the company.

Positives

• The amendment provides transparency and corrects a previous error in reporting.

Negatives

• The need for an amendment indicates an initial oversight in reporting the stock sale.

Risks

• None apparent in this document.

Industry Context

Form 4 filings are standard practice for reporting transactions by company insiders, ensuring transparency in the market.

Comparison to Industry Standards

• Form 4 filings are a standard regulatory requirement for corporate insiders in the US, similar to insider transaction reporting requirements in other developed markets.
• The level of detail provided in the filing is consistent with SEC guidelines and industry best practices for transparency.

Stakeholder Impact

• The correction of the Form 4 filing ensures accurate information is available to shareholders.

Key Dates

Keywords

Form 4, amendment, NeuroMetrix, Joshua Horowitz, stock sale, RSUs, restricted stock units, beneficial ownership, director compensation